Eli Lilly, Novo waging price wars as obesity drug market heats up in China
Source: SeekingAlpha
2025-12-30 07:43:40 ET
More on Eli Lilly, Novo Nordisk
- Novo Nordisk: The Real Comeback Starts Now With The Wegovy Pill
- Eli Lilly: Mr. Market Finally Woke Up, But I'm Not Out Yet (Rating Downgrade)
- Eli Lilly: Short-Term Upside Exhausted (Rating Downgrade)
- CMS unveils payment model to boost GLP-1 access for Medicare Part D, Medicaid
- GLP-1 weight loss meds lead to changes in consumer food demand - study
Read the full article on Seeking Alpha
For further details see:
Eli Lilly, Novo waging price wars as obesity drug market heats up in China
Innovent Biologics Inc
NASDAQ: IVBXF
IVBXF Trading
-1.19% G/L:
$9.95 Last:
8,095 Volume:
$10 Open:
